Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis.

导出 LinkOut

翻译打印收藏纠错

第一作者： Sung Hye,Kong

第一单位： Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

作者： Sung Hye,Kong ^[1] ; Jung Hee,Kim ^[2] ; Sang Wan,Kim ^[2] ; Ae Jin,Jeong ^[3] ; Song-Hee,Lee ^[2] ; Sang-Kyu,Ye ^[4] ; Chan Soo,Shin ^[5]

作者单位： Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. ^[1] Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. ^[2] Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea. ^[3] Division of Endocrinology and Metabolism, Department of Internal Medicine, Boramae Medical Center, Seoul, Korea. ^[4] Department of Pharmacology and Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea. ^[5]

关键词 Denosumab Osteoclasts Osteoporosis Zoledronic acid

DOI 10.11005/jbm.2022.29.2.93

PMID 35718926

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of bone metabolism

2022年29卷2期

93-101页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis.

Journal of bone metabolism

相似文献

Journal of bone metabolism

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Effect of Denosumab on the Change of Osteoclast Precursors Compared to Zoledronate Treatment in Postmenopausal Women with Osteoporosis.

Journal of bone metabolism

相似文献

Journal of bone metabolism

相关期刊

检索历史清除